Navigation Links
PharmaNet Development Group, Inc. to Announce Fourth Quarter and Full Year 2008 Financial Results on February 25, 2009
Date:2/5/2009

d pharmaceutical, biotechnology, generic drug and medical device industries, the reduction of expenditures by branded pharmaceutical, biotechnology, generic drug or medical device companies, actions or inspections by regulatory authorities and the impact on our clients' decisions to not award future contracts to us or to cancel existing contracts, the impact of healthcare reform, the fact that one or a limited number of clients may account for a large percentage of our revenues, the incurrence of significant taxes to repatriate funds, the fluctuation of our operating results from period to period, our assessment of our goodwill valuation, the impact of foreign currency fluctuations, tax law changes in Canada or in other foreign jurisdictions, investigations by governmental authorities regarding our inter-company transfer pricing policies or changes to their laws in a manner that could increase our effective tax rate or otherwise harm our business, our lack of the resources needed to compete effectively with larger competitors, our ability to continue to develop new assay methods for our analytical applications, or if our current assay methods are incorrect, our ability to compete with other entities offering bioanalytical laboratory services, our potential liability when conducting clinical trials, our handling and disposal of medical wastes, failure to comply with applicable governmental regulations, the loss of services of our key personnel and our ability to attract qualified staff, the continued effectiveness and availability of our information technology infrastructure, losses related to our self-insurance of our employees' healthcare costs in the United States, our ability to attract suitable investigators and volunteers for our clinical trials, the material weaknesses relating to our internal controls, and risks and uncertainties associated with discontinued operations.

Further information can be found in the Company's risk factors contained
'/>"/>

SOURCE PharmaNet Development Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Law Offices of Howard G. Smith Announces Class Action Lawsuit on Behalf of Investors of PharmaNet Development Group, Inc.
2. Isolation of a new gene family essential for early development
3. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
4. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
5. Ovation further advances development pipeline with new phase III epilepsy study
6. Pioneer Surgical Technology Hires Vice President of New Business Development
7. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
8. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. Optim To Assist Prairie Community Health Center with Construction Scope Development
11. Nick Childs Joins Grey New York as Director of Content Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... (PRWEB) April 24, 2015 National ... informed and legal access to medical cannabis, is taking ... properly supported when advising patients. , NAC is the ... Program. With a $250,000 grant, NAC will be providing ... , "Our goal is to help Canadians gain safe ...
(Date:4/24/2015)... Telematics Berlin is the foremost Automotive Data ... 2 suppliers, content providers, associations and government bodies. From ... chain, see them converge in Berlin. This year’s start-up ... those companies currently at the forefront of Europe’s Silicon ... customer centric products, ParkTAG are one of the first ...
(Date:4/24/2015)... New York (PRWEB) April 24, 2015 ... partnered with Allergy and Asthma Network (The Network), a ... PURE Solutions will provide news, tips and information for ... The Network’s newly redesigned website. , The goal for ... awareness about the travel needs of people with asthma ...
(Date:4/24/2015)... 2015 ProTube Outro is a set of ... editors. ProTube Outro allows editors to easily manipulate the ... zones. Position, scale, and rotate pictures/videos, logos, social media ... uses simple borders and shadows for a minimalistic and versatile ... ProTube Outro comes packed with over 30 customizable outro screen ...
(Date:4/23/2015)... 23, 2015 On April 8th, 2015, ... Movie Awards” EcoLuxe Lounge at the famous Avalon Hollywood. ... product placement in TV and film, the EcoLuxe Lounge ... at several awards ceremonies and festivals throughout the year, ... sound and socially conscious products and services together for ...
Breaking Medicine News(10 mins):Health News:National Access Cannabis Gives 300 Canadian Healthcare Professionals Access to Medical Cannabis Certificate Program 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 3Health News:PURE Solutions Partners with Allergy and Asthma Network to Provide Allergy Travel Tips 2Health News:Pixel Film Studios, FCPX Plugin Developer Announced the Release of Protube Outro, Outro Screen Templates for Final Cut Pro X 2Health News:Choices Recovery South Bend Talks With Neal Cohen About Long-Term Sobriety 2
... ... ... ... TULSA, Okla. , Feb. 19 U.S. Attorney Thomas Scott ...
... in multinational communities, researchers say , FRIDAY, Feb. 19 (HealthDay ... taught in the accent of the listener, a new study ... adults in the "original" accent of the new language. But ... this method isn,t necessarily the best or quickest way to ...
... The American Association for Dental Research (AADR) is ... Harkin will be recognized at the AADR/Research!America Advocacy Day, ... is being recognized for his commitment to the National ... Dental and Craniofacial Research (NIDCR). He remains one of ...
... a national poll aimed at helping with planning efforts ... attack, researchers at the Harvard School of Public Health ... scenario describing a significant anthrax attack in their city ... health recommendations to obtain prophylactic antibiotics. However, a significant ...
... discovery could lead to new treatments, study suggests , FRIDAY, ... treatments for cystic fibrosis, U.S. researchers have identified a defective ... lung disease. , Cystic fibrosis causes thick, sticky mucus to ... one of the most common potentially lethal genetic diseases in ...
... ... ... , , ... ...
Cached Medicine News:Health News:Two Tulsa Pharmacies Penalized for Missing Prescription Drugs 2Health News:Two Tulsa Pharmacies Penalized for Missing Prescription Drugs 3Health News:Second Language Comes Faster When Taught in Own Accent 2Health News:AADR presents honorary membership to Senator Tom Harkin 2Health News:Poll: Hypothetical anthrax attack and antibiotics 2Health News:Poll: Hypothetical anthrax attack and antibiotics 3Health News:Poll: Hypothetical anthrax attack and antibiotics 4Health News:Poll: Hypothetical anthrax attack and antibiotics 5Health News:Poll: Hypothetical anthrax attack and antibiotics 6Health News:Drug Improved Survival in Mice With Cystic Fibrosis 2Health News:Registered Nurses from Public Health - Seattle & King County Hold Informational Picket to Highlight Public Safety Concerns 2Health News:Registered Nurses from Public Health - Seattle & King County Hold Informational Picket to Highlight Public Safety Concerns 3
(Date:4/24/2015)... , Apr. 24, 2015 Research ... has announced the addition of the ... Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station) & End ... - Global Forecast to 2020" report ... laboratory accessories market is expected to reach ...
(Date:4/24/2015)... The National Institute of Allergy and ... of Health [NIH])  provided grants totaling more than ... development of diagnostic tests for antibiotic-resistant bacteria . ... health facilities , the NIAID and other government ... effective tests using alternative methods to traditional culturing.   ...
(Date:4/24/2015)... , April 24, 2015 /CNW/ - T-Bird Pharma ... focused on developing premium quality medical marijuana products and ... Marihuana for Medical Purposes Regulations ( Canada ... with certain of its shareholders, has closed the transaction ... ("Medna").  Medna has acquired (the "Escrow Transfer") a total ...
Breaking Medicine Technology:Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 3Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 3
... Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces ... bioavailable, highly selective, class I histone deacetylase (HDAC) inhibitor, ... being presented as oral poster discussions at the San ... in San Antonio Texas. The following ...
... AUSTIN, Texas, Dec. 10, 2010 Hanger Orthopedic Group, Inc. ... the previously announced public offering of 2,000,000 shares of its ... public offering price of $20.00 per share.  The transaction is ... were a portion of the currently outstanding shares issued to ...
Cached Medicine Technology:Syndax Pharmaceuticals' Entinostat in Combination Shows Activity in Breast Cancer 2Syndax Pharmaceuticals' Entinostat in Combination Shows Activity in Breast Cancer 3Syndax Pharmaceuticals' Entinostat in Combination Shows Activity in Breast Cancer 4Hanger Orthopedic Group, Inc. Announces Pricing of Underwritten Public Offering by Shareholder 2Hanger Orthopedic Group, Inc. Announces Pricing of Underwritten Public Offering by Shareholder 3
... microscopes utilize the infinity-corrected optical ... operability in cell checking. The ... microscope suited to routine applications ... tissue culture and embryology to ...
... from the ground-up with ergonomic concerns in ... most adjustable observation tube on the market. ... user can adjust the microscope to suit ... the operator maintain an upright, comfortable posture, ...
... A standard laboratory microscope whose ... imagery combine to make it ... E400 is designed to fit ... the user to fit the ...
... through the enclosed polaroid glasses, these ... screening devise for near point stereopsis ... stereo perception, the images appear to ... The test includes circle patterns for ...
Medicine Products: